APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Mutagenesis Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gene Mutagenesis Service Market Analysis and Forecast 2026-2032

4 March 2026194 pages

Choose your research edition.

Industry ResearchGene Mutagenesis Service Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Mutagenesis Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Gene Mutagenesis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Mutagenesis Service Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Mutagenesis Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Gene Mutagenesis Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gene Mutagenesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gene Mutagenesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gene Mutagenesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gene Mutagenesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gene Mutagenesis Service include Thermofisher, Azenta Life Sciences, Creative Biogene, Charles River, ACGT, Vectorbuilder, Creative Biolabs, Bio Basic and Applied Biological Materials, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gene Mutagenesis Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gene Mutagenesis Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Gene Mutagenesis Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Mutagenesis Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gene Mutagenesis Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gene Mutagenesis Service revenue, projected growth trends, production technology, application and end-user industry.

Gene Mutagenesis Service Segment by Company

Thermofisher

Azenta Life Sciences

Creative Biogene

Charles River

ACGT

Vectorbuilder

Creative Biolabs

Bio Basic

Applied Biological Materials

NovoPro Bioscience

Abace-Biology

Sangon Biotech

Genscript

Beijing Tsingke Biotech

Gene Mutagenesis Service Segment by Type

Site-Directed Mutagenesis

Random Mutagenesis

Gene Mutagenesis Service Segment by Application

Pharmaceutical Industry

Research

Others

Gene Mutagenesis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Mutagenesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Mutagenesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Mutagenesis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Gene Mutagenesis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Gene Mutagenesis Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Mutagenesis Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Mutagenesis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Site-Directed Mutagenesis Major Player Table 3. Random Mutagenesis Major Player Table 4. Global Gene Mutagenesis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical Industry Major Player Table 6. Research Major Player Table 7. Others Major Player Table 8. Gene Mutagenesis Service Industry Trends Table 9. Gene Mutagenesis Service Industry Drivers Table 10. Gene Mutagenesis Service Industry Opportunities and Challenges Table 11. Gene Mutagenesis Service Industry Restraints Table 12. Global Gene Mutagenesis Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Gene Mutagenesis Service Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Gene Mutagenesis Service Market Share by Region (2021-2026) Table 15. Global Gene Mutagenesis Service Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Gene Mutagenesis Service Market Share by Region (2027-2032) Table 17. Global Gene Mutagenesis Service Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Gene Mutagenesis Service Revenue Market Share by Players (2021-2026) Table 19. Global Gene Mutagenesis Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Gene Mutagenesis Service Key Players Headquarters & Area Served Table 21. Global Gene Mutagenesis Service Players, Product Type & Application Table 22. Global Gene Mutagenesis Service Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Gene Mutagenesis Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Gene Mutagenesis Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gene Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Gene Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Gene Mutagenesis Service Revenue Market Share by Type (2021-2026) Table 29. Global Gene Mutagenesis Service Revenue Market Share by Type (2027-2032) Table 30. Global Gene Mutagenesis Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Gene Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Gene Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Gene Mutagenesis Service Revenue Market Share by Application (2021-2026) Table 34. Global Gene Mutagenesis Service Revenue Market Share by Application (2027-2032) Table 35. Thermofisher Company Information Table 36. Thermofisher Business Overview Table 37. Thermofisher Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Thermofisher Gene Mutagenesis Service Product Portfolio Table 39. Thermofisher Recent Development Table 40. Azenta Life Sciences Company Information Table 41. Azenta Life Sciences Business Overview Table 42. Azenta Life Sciences Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Azenta Life Sciences Gene Mutagenesis Service Product Portfolio Table 44. Azenta Life Sciences Recent Development Table 45. Creative Biogene Company Information Table 46. Creative Biogene Business Overview Table 47. Creative Biogene Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Creative Biogene Gene Mutagenesis Service Product Portfolio Table 49. Creative Biogene Recent Development Table 50. Charles River Company Information Table 51. Charles River Business Overview Table 52. Charles River Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Charles River Gene Mutagenesis Service Product Portfolio Table 54. Charles River Recent Development Table 55. ACGT Company Information Table 56. ACGT Business Overview Table 57. ACGT Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. ACGT Gene Mutagenesis Service Product Portfolio Table 59. ACGT Recent Development Table 60. Vectorbuilder Company Information Table 61. Vectorbuilder Business Overview Table 62. Vectorbuilder Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Vectorbuilder Gene Mutagenesis Service Product Portfolio Table 64. Vectorbuilder Recent Development Table 65. Creative Biolabs Company Information Table 66. Creative Biolabs Business Overview Table 67. Creative Biolabs Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Creative Biolabs Gene Mutagenesis Service Product Portfolio Table 69. Creative Biolabs Recent Development Table 70. Bio Basic Company Information Table 71. Bio Basic Business Overview Table 72. Bio Basic Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Bio Basic Gene Mutagenesis Service Product Portfolio Table 74. Bio Basic Recent Development Table 75. Applied Biological Materials Company Information Table 76. Applied Biological Materials Business Overview Table 77. Applied Biological Materials Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Applied Biological Materials Gene Mutagenesis Service Product Portfolio Table 79. Applied Biological Materials Recent Development Table 80. NovoPro Bioscience Company Information Table 81. NovoPro Bioscience Business Overview Table 82. NovoPro Bioscience Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. NovoPro Bioscience Gene Mutagenesis Service Product Portfolio Table 84. NovoPro Bioscience Recent Development Table 85. Abace-Biology Company Information Table 86. Abace-Biology Business Overview Table 87. Abace-Biology Gene Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Abace-Biology Gene Mutagenesis Service Product Portfolio Table 89. Abace-Biology Recent Development Table 90. Sangon Biotech Company Information Table 91. Sangon Biotech Business Overview Table 92. Sangon Biotech Gene Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Sangon Biotech Gene Mutagenesis Service Product Portfolio Table 94. Sangon Biotech Recent Development Table 95. Genscript Company Information Table 96. Genscript Business Overview Table 97. Genscript Gene Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Genscript Gene Mutagenesis Service Product Portfolio Table 99. Genscript Recent Development Table 100. Beijing Tsingke Biotech Company Information Table 101. Beijing Tsingke Biotech Business Overview Table 102. Beijing Tsingke Biotech Gene Mutagenesis Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Beijing Tsingke Biotech Gene Mutagenesis Service Product Portfolio Table 104. Beijing Tsingke Biotech Recent Development Table 105. North America Gene Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Gene Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Gene Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Gene Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Gene Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Gene Mutagenesis Service Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Gene Mutagenesis Service Revenue by Country (US$ Million) & (2027-2032) Table 112. Europe Gene Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Gene Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Gene Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Gene Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Gene Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Gene Mutagenesis Service Revenue by Country (2021-2026) & (US$ Million) Table 118. Europe Gene Mutagenesis Service Revenue by Country (US$ Million) & (2027-2032) Table 119. China Gene Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 120. China Gene Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 121. China Gene Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 122. China Gene Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Gene Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 124. Asia Gene Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 125. Asia Gene Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 126. Asia Gene Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Gene Mutagenesis Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Gene Mutagenesis Service Revenue by Region (US$ Million) & (2021-2026) Table 129. Asia Gene Mutagenesis Service Revenue by Region (US$ Million) & (2027-2032) Table 130. SAMEA Gene Mutagenesis Service Revenue by Type (2021-2026) & (US$ Million) Table 131. SAMEA Gene Mutagenesis Service Revenue by Type (2027-2032) & (US$ Million) Table 132. SAMEA Gene Mutagenesis Service Revenue by Application (2021-2026) & (US$ Million) Table 133. SAMEA Gene Mutagenesis Service Revenue by Application (2027-2032) & (US$ Million) Table 134. SAMEA Gene Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. SAMEA Gene Mutagenesis Service Revenue by Country (2021-2026) & (US$ Million) Table 136. SAMEA Gene Mutagenesis Service Revenue by Country (US$ Million) & (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Gene Mutagenesis Service Image Figure 2. Global Gene Mutagenesis Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Mutagenesis Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Site-Directed Mutagenesis Image Figure 5. Random Mutagenesis Image Figure 6. Global Gene Mutagenesis Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Gene Mutagenesis Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical Industry Image Figure 9. Research Image Figure 10. Others Image Figure 11. Global Gene Mutagenesis Service Market Size (US$ Million) & (2021-2032) Figure 12. Global Gene Mutagenesis Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gene Mutagenesis Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Gene Mutagenesis Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Gene Mutagenesis Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Gene Mutagenesis Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Gene Mutagenesis Service Revenue Market Share by Type (2021-2032) Figure 19. Global Gene Mutagenesis Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gene Mutagenesis Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Gene Mutagenesis Service Revenue Market Share by Application (2021-2032) Figure 22. North America Gene Mutagenesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Gene Mutagenesis Service Revenue Share by Type (2021-2032) Figure 24. North America Gene Mutagenesis Service Revenue Share by Application (2021-2032) Figure 25. North America Gene Mutagenesis Service Revenue Share by Country (2021-2032) Figure 26. United States Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Gene Mutagenesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Gene Mutagenesis Service Revenue Share by Type (2021-2032) Figure 31. Europe Gene Mutagenesis Service Revenue Share by Application (2021-2032) Figure 32. Europe Gene Mutagenesis Service Revenue Share by Country (2021-2032) Figure 33. Germany Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Gene Mutagenesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Gene Mutagenesis Service Revenue Share by Type (2021-2032) Figure 43. China Gene Mutagenesis Service Revenue Share by Application (2021-2032) Figure 44. Asia Gene Mutagenesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Gene Mutagenesis Service Revenue Share by Type (2021-2032) Figure 46. Asia Gene Mutagenesis Service Revenue Share by Application (2021-2032) Figure 47. Asia Gene Mutagenesis Service Revenue Share by Region (2021-2032) Figure 48. Japan Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Gene Mutagenesis Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Gene Mutagenesis Service Revenue Share by Type (2021-2032) Figure 56. SAMEA Gene Mutagenesis Service Revenue Share by Application (2021-2032) Figure 57. SAMEA Gene Mutagenesis Service Revenue Share by Country (2021-2032) Figure 58. Brazil Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Gene Mutagenesis Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Site-Directed Mutagenesis
  • Random Mutagenesis
Applications
  • Pharmaceutical Industry
  • Research
  • Others
Companies covered
  • Thermofisher
  • Azenta Life Sciences
  • Creative Biogene
  • Charles River
  • ACGT
  • Vectorbuilder
  • Creative Biolabs
  • Bio Basic
  • Applied Biological Materials
  • NovoPro Bioscience
  • Abace-Biology
  • Sangon Biotech
  • Genscript
  • Beijing Tsingke Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gene Mutagenesis Service Market by Type
  3. 1.2.1 Global Gene Mutagenesis Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Site-Directed Mutagenesis
  5. 1.2.3 Random Mutagenesis
  6. 1.3 Gene Mutagenesis Service Market by Application
  7. 1.3.1 Global Gene Mutagenesis Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical Industry
  9. 1.3.3 Research
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Gene Mutagenesis Service Market Dynamics
  1. 2.1 Gene Mutagenesis Service Industry Trends
  2. 2.2 Gene Mutagenesis Service Industry Drivers
  3. 2.3 Gene Mutagenesis Service Industry Opportunities and Challenges
  4. 2.4 Gene Mutagenesis Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Gene Mutagenesis Service Market Perspective (2021-2032)
  2. 3.2 Global Gene Mutagenesis Service Growth Trends by Region
  3. 3.2.1 Global Gene Mutagenesis Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gene Mutagenesis Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Gene Mutagenesis Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Gene Mutagenesis Service Revenue by Players
  2. 4.1.1 Global Gene Mutagenesis Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Gene Mutagenesis Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Gene Mutagenesis Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gene Mutagenesis Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Gene Mutagenesis Service Key Players Headquarters & Area Served
  7. 4.4 Global Gene Mutagenesis Service Players, Product Type & Application
  8. 4.5 Global Gene Mutagenesis Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Gene Mutagenesis Service Market CR5 and HHI
  11. 4.6.3 2025 Gene Mutagenesis Service Tier 1, Tier 2, and Tier 3
5 Gene Mutagenesis Service Market Size by Type
  1. 5.1 Global Gene Mutagenesis Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Mutagenesis Service Revenue by Type (2021-2032)
  3. 5.3 Global Gene Mutagenesis Service Revenue Market Share by Type (2021-2032)
6 Gene Mutagenesis Service Market Size by Application
  1. 6.1 Global Gene Mutagenesis Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Gene Mutagenesis Service Revenue by Application (2021-2032)
  3. 6.3 Global Gene Mutagenesis Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermofisher
  2. 7.1.1 Thermofisher Company Information
  3. 7.1.2 Thermofisher Business Overview
  4. 7.1.3 Thermofisher Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermofisher Gene Mutagenesis Service Product Portfolio
  6. 7.1.5 Thermofisher Recent Developments
  7. 7.2 Azenta Life Sciences
  8. 7.2.1 Azenta Life Sciences Company Information
  9. 7.2.2 Azenta Life Sciences Business Overview
  10. 7.2.3 Azenta Life Sciences Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Azenta Life Sciences Gene Mutagenesis Service Product Portfolio
  12. 7.2.5 Azenta Life Sciences Recent Developments
  13. 7.3 Creative Biogene
  14. 7.3.1 Creative Biogene Company Information
  15. 7.3.2 Creative Biogene Business Overview
  16. 7.3.3 Creative Biogene Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Creative Biogene Gene Mutagenesis Service Product Portfolio
  18. 7.3.5 Creative Biogene Recent Developments
  19. 7.4 Charles River
  20. 7.4.1 Charles River Company Information
  21. 7.4.2 Charles River Business Overview
  22. 7.4.3 Charles River Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Charles River Gene Mutagenesis Service Product Portfolio
  24. 7.4.5 Charles River Recent Developments
  25. 7.5 ACGT
  26. 7.5.1 ACGT Company Information
  27. 7.5.2 ACGT Business Overview
  28. 7.5.3 ACGT Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ACGT Gene Mutagenesis Service Product Portfolio
  30. 7.5.5 ACGT Recent Developments
  31. 7.6 Vectorbuilder
  32. 7.6.1 Vectorbuilder Company Information
  33. 7.6.2 Vectorbuilder Business Overview
  34. 7.6.3 Vectorbuilder Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Vectorbuilder Gene Mutagenesis Service Product Portfolio
  36. 7.6.5 Vectorbuilder Recent Developments
  37. 7.7 Creative Biolabs
  38. 7.7.1 Creative Biolabs Company Information
  39. 7.7.2 Creative Biolabs Business Overview
  40. 7.7.3 Creative Biolabs Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative Biolabs Gene Mutagenesis Service Product Portfolio
  42. 7.7.5 Creative Biolabs Recent Developments
  43. 7.8 Bio Basic
  44. 7.8.1 Bio Basic Company Information
  45. 7.8.2 Bio Basic Business Overview
  46. 7.8.3 Bio Basic Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bio Basic Gene Mutagenesis Service Product Portfolio
  48. 7.8.5 Bio Basic Recent Developments
  49. 7.9 Applied Biological Materials
  50. 7.9.1 Applied Biological Materials Company Information
  51. 7.9.2 Applied Biological Materials Business Overview
  52. 7.9.3 Applied Biological Materials Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Applied Biological Materials Gene Mutagenesis Service Product Portfolio
  54. 7.9.5 Applied Biological Materials Recent Developments
  55. 7.10 NovoPro Bioscience
  56. 7.10.1 NovoPro Bioscience Company Information
  57. 7.10.2 NovoPro Bioscience Business Overview
  58. 7.10.3 NovoPro Bioscience Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 NovoPro Bioscience Gene Mutagenesis Service Product Portfolio
  60. 7.10.5 NovoPro Bioscience Recent Developments
  61. 7.11 Abace-Biology
  62. 7.11.1 Abace-Biology Company Information
  63. 7.11.2 Abace-Biology Business Overview
  64. 7.11.3 Abace-Biology Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Abace-Biology Gene Mutagenesis Service Product Portfolio
  66. 7.11.5 Abace-Biology Recent Developments
  67. 7.12 Sangon Biotech
  68. 7.12.1 Sangon Biotech Company Information
  69. 7.12.2 Sangon Biotech Business Overview
  70. 7.12.3 Sangon Biotech Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Sangon Biotech Gene Mutagenesis Service Product Portfolio
  72. 7.12.5 Sangon Biotech Recent Developments
  73. 7.13 Genscript
  74. 7.13.1 Genscript Company Information
  75. 7.13.2 Genscript Business Overview
  76. 7.13.3 Genscript Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Genscript Gene Mutagenesis Service Product Portfolio
  78. 7.13.5 Genscript Recent Developments
  79. 7.14 Beijing Tsingke Biotech
  80. 7.14.1 Beijing Tsingke Biotech Company Information
  81. 7.14.2 Beijing Tsingke Biotech Business Overview
  82. 7.14.3 Beijing Tsingke Biotech Gene Mutagenesis Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Beijing Tsingke Biotech Gene Mutagenesis Service Product Portfolio
  84. 7.14.5 Beijing Tsingke Biotech Recent Developments
8 North America
  1. 8.1 North America Gene Mutagenesis Service Revenue (2021-2032)
  2. 8.2 North America Gene Mutagenesis Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Gene Mutagenesis Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Gene Mutagenesis Service Revenue by Type (2027-2032)
  5. 8.3 North America Gene Mutagenesis Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Gene Mutagenesis Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Gene Mutagenesis Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Gene Mutagenesis Service Revenue by Application (2027-2032)
  9. 8.5 North America Gene Mutagenesis Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Gene Mutagenesis Service Revenue by Country
  11. 8.6.1 North America Gene Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Gene Mutagenesis Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Gene Mutagenesis Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Gene Mutagenesis Service Revenue (2021-2032)
  2. 9.2 Europe Gene Mutagenesis Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Gene Mutagenesis Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Gene Mutagenesis Service Revenue by Type (2027-2032)
  5. 9.3 Europe Gene Mutagenesis Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Gene Mutagenesis Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Gene Mutagenesis Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Gene Mutagenesis Service Revenue by Application (2027-2032)
  9. 9.5 Europe Gene Mutagenesis Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Gene Mutagenesis Service Revenue by Country
  11. 9.6.1 Europe Gene Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Gene Mutagenesis Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Gene Mutagenesis Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Gene Mutagenesis Service Revenue (2021-2032)
  2. 10.2 China Gene Mutagenesis Service Revenue by Type (2021-2032)
  3. 10.2.1 China Gene Mutagenesis Service Revenue by Type (2021-2026)
  4. 10.2.2 China Gene Mutagenesis Service Revenue by Type (2027-2032)
  5. 10.3 China Gene Mutagenesis Service Revenue Share by Type (2021-2032)
  6. 10.4 China Gene Mutagenesis Service Revenue by Application (2021-2032)
  7. 10.4.1 China Gene Mutagenesis Service Revenue by Application (2021-2026)
  8. 10.4.2 China Gene Mutagenesis Service Revenue by Application (2027-2032)
  9. 10.5 China Gene Mutagenesis Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gene Mutagenesis Service Revenue (2021-2032)
  2. 11.2 Asia Gene Mutagenesis Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Gene Mutagenesis Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Gene Mutagenesis Service Revenue by Type (2027-2032)
  5. 11.3 Asia Gene Mutagenesis Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Gene Mutagenesis Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Gene Mutagenesis Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Gene Mutagenesis Service Revenue by Application (2027-2032)
  9. 11.5 Asia Gene Mutagenesis Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Gene Mutagenesis Service Revenue by Country
  11. 11.6.1 Asia Gene Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Gene Mutagenesis Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Gene Mutagenesis Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gene Mutagenesis Service Revenue (2021-2032)
  2. 12.2 SAMEA Gene Mutagenesis Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Gene Mutagenesis Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Gene Mutagenesis Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Gene Mutagenesis Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Gene Mutagenesis Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Gene Mutagenesis Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Gene Mutagenesis Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Gene Mutagenesis Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Gene Mutagenesis Service Revenue by Country
  11. 12.6.1 SAMEA Gene Mutagenesis Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Gene Mutagenesis Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Gene Mutagenesis Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst